As of 2025-08-06, the Intrinsic Value of Atea Pharmaceuticals Inc (AVIR) is -40.89 USD. This Atea valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.52 USD, the upside of Atea Pharmaceuticals Inc is -1,261.58%.
Based on its market price of 3.52 USD and our intrinsic valuation, Atea Pharmaceuticals Inc (AVIR) is overvalued by 1,261.58%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -40.89 - -40.89 | -40.89 | -1,261.58% |
| P/E | (29.21) - (30.65) | (30.99) | -980.5% |
| DDM - Stable | (9.85) - (24.72) | (17.29) | -591.1% |
| DDM - Multi | (9.84) - (19.83) | (13.22) | -475.6% |
| Market Cap (mil) | 301.24 |
| Beta | 0.81 |
| Outstanding shares (mil) | 85.58 |
| Enterprise Value (mil) | 181.85 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.79% |
| Cost of Debt | 5.00% |
| WACC | 8.86% |